Novo Integrated Sciences’ IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada

Rhea-AI Summary

Novo Integrated Sciences (NASDAQ: NVOS) announced that its subsidiary, Novo Healthnet Limited, received a Natural Product Number (NPN) from Health Canada for its IoNovo Iodide product. This marks the third iodine-based product to be approved, following IoNovo Iodine and IoNovo for Kids, which are all developed by Terragenx Inc., a fully owned subsidiary. Iodide is recognized for its contributions to healthy metabolism and cognitive function. The IoNovo line is available for purchase via the Terragenx e-commerce platform, highlighting Novo's commitment to innovative health solutions.

Positive

• NPN granted for IoNovo Iodide by Health Canada, enhancing product portfolio.
• Third iodine product launched, indicating strong product development.
• IoNovo products designed for better absorption compared to traditional forms.

Negative

• None.

BELLEVUE, Wash.--(BUSINESS WIRE)-- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation, today announced that its wholly owned subsidiary, Novo Healthnet Limited, has been granted a Natural Product Number (NPN) by Health Canada for its IoNovo Iodide branded product. A NPN is a product license assessed and granted by Health Canada for Natural Health Products determined to be safe, effective, of high quality, and eligible for sale in Canada.

IoNovo Iodide is Novo’s 3^rd iodine related product to recently be granted a NPN by Health Canada following both IoNovo Iodine and IoNovo for Kids pure iodine oral spray. The IoNovo product lines are developed, manufactured, and sold by Terragenx Inc., a recently acquired wholly-owned Novo subsidiary.

For decades, the global medical community has recognized iodide as an essential micronutrient that assists the thyroid to produce T3 and T4 hormones needed for a healthy metabolism, immune system, increased energy levels, and cognitive development. Additionally, iodide is known to promote healthy skin, nails, and hair. IoNovo Iodide is directly absorbed into the bloodstream through a precise oral spray dosage without interacting with the oral micro-biome or any bacteria or viruses.

All of Novo’s IoNovo products are designed to be delivered via oral spray which is proven to be significantly more effective in absorption than pill or gel capsules. IoNovo Iodide and IoNovo Iodine are available for purchase on the Terragenx e-commerce website (www.terragenx.com).

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.

We believe that “decentralizing” healthcare, through the integration of medical technology and interconnectivity, is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and in the future. Specific to non-critical care, ongoing advancements in both medical technology and inter-connectivity are allowing for a shift of the patient/practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions as well as allowing for more cost-effective healthcare distribution.

The Company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers:

• First Pillar: Service Networks. Deliver multidisciplinary primary care services through (i) an affiliate network of clinic facilities, (ii) small and micro footprint sized clinic facilities primarily located within the footprint of box-store commercial enterprises, (iii) clinic facilities operated through a franchise relationship with the Company, and (iv) corporate operated clinic facilities.
• Second Pillar: Technology. Develop, deploy, and integrate sophisticated interconnected technology, interfacing the patient to the healthcare practitioner thus expanding the reach and availability of the Company’s services, beyond the traditional clinic location, to geographic areas not readily providing advanced, peripheral based healthcare services, including the patient’s home.
• Third Pillar: Products. Develop and distribute effective, personalized health and wellness product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier population. The Company’s science-first approach to product innovation further emphasizes our mandate to create and provide over-the-counter preventative and maintenance care solutions.

Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.

For more information concerning Novo Integrated Sciences, please visit www.novointegrated.com . For more information on Novo Healthnet Limited, Novo’s wholly owned subsidiary, please visit www.novohealthnet.com.

Twitter, LinkedIn, Facebook, Instagram, YouTube

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," “intend,” "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in Novo’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond Novo’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Novo’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Novo assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005407/en/

Chris David, COO-President

Novo Integrated Sciences, Inc.

chris.david@novointegrated.com

(888) 512-1195

Source: Novo Integrated Sciences, Inc.

FAQ

What is the recent news about Novo Integrated Sciences (NVOS)?

Novo Integrated Sciences announced that its subsidiary, Novo Healthnet Limited, received an NPN for its IoNovo Iodide product from Health Canada.

How many products does Novo Integrated Sciences have approved by Health Canada?

Novo Integrated Sciences has three iodine-related products approved by Health Canada, including IoNovo Iodide, IoNovo Iodine, and IoNovo for Kids.

Where can I buy IoNovo Iodide from Novo Integrated Sciences?

IoNovo Iodide is available for purchase on the Terragenx e-commerce website.

What benefits does iodide provide according to Novo Integrated Sciences?

Iodide is recognized for supporting healthy metabolism, immune function, and cognitive development.

What is the focus of Novo Integrated Sciences in healthcare?

Novo Integrated Sciences focuses on a holistic approach to health and wellness through innovative healthcare products and services.